Infectious Diseases (except HIV/AIDS)

  1. Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine

    1. Sabryna Nantel
    2. Benoîte Bourdin
    3. Kelsey Adams
    4. Julie Carbonneau
    5. Henintsoa Rabezanahary
    6. Marie-Ève Hamelin
    7. Deirdre McCormack
    8. Patrice Savard
    9. Yves Longtin
    10. Matthew P. Cheng
    11. Gaston De Serres
    12. Jacques Corbeil
    13. Vladimir Gilca
    14. Mariana Baz
    15. Guy Boivin
    16. Caroline Quach
    17. Hélène Decaluwe

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Predictors of all‐cause mortality among patients hospitalized with influenza, respiratory syncytial virus, or SARS‐CoV‐2

    1. Mackenzie A. Hamilton
    2. Ying Liu
    3. Andrew Calzavara
    4. Maria E. Sundaram
    5. Mohamed Djebli
    6. Dariya Darvin
    7. Stefan Baral
    8. Rafal Kustra
    9. Jeffrey C. Kwong
    10. Sharmistha Mishra

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Correlates of protection, viral load trajectories and symptoms in BA.1, BA.1.1 and BA.2 breakthrough infections in triple vaccinated healthcare workers

    1. Ulrika Marking
    2. Sebastian Havervall
    3. Nina Greilert Norin
    4. Oscar Bladh
    5. Wanda Christ
    6. Max Gordon
    7. Henry Ng
    8. Kim Blom
    9. Mia Phillipson
    10. Sara Mangsbo
    11. Anna Smed Sörensen
    12. Peter Nilsson
    13. Sophia Hober
    14. Mikael Åberg
    15. Jonas Klingström
    16. Charlotte Thålin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. COVID-19 vaccination coverage by company size and the effects of socioeconomic factors and workplace vaccination in Japan: a cohort study

    1. Koji Mori
    2. Takahiro Mori
    3. Tomohisa Nagata
    4. Hajime Ando
    5. Ayako Hino
    6. Seiichiro Tateishi
    7. Mayumi Tsuji
    8. Keiji Muramatsu
    9. Yoshihisa Fujino
    10. the CORoNa Work Project

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Demonstration of Antibodies Against SARS-CoV-2, Neutralizing or Binding, in Seroconversion Panels After mRNA-1273, BNT-162b2, and Ad26.COV2.S Vaccine Administration

    1. Francisco Belda
    2. Oscar Mora
    3. Monica Lopez-Martinez
    4. Nerea Torres
    5. Ana Vivanco
    6. Silvia Marfil
    7. Edwards Pradenas
    8. Marta Massanella
    9. Julià Blanco
    10. Rebecca Christie
    11. Michael Crowley

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial

    1. Joon Young Song
    2. Won Suk Choi
    3. Jung Yeon Heo
    4. Jin Soo Lee
    5. Dong Sik Jung
    6. Shin-Woo Kim
    7. Kyung-Hwa Park
    8. Joong Sik Eom
    9. Su Jin Jeong
    10. Jacob Lee
    11. Ki Tae Kwon
    12. Hee Jung Choi
    13. Jang Wook Sohn
    14. Young Keun Kim
    15. Ji Yun Noh
    16. Woo Joo Kim
    17. François Roman
    18. Maria Angeles Ceregido
    19. Francesca Solmi
    20. Agathe Philippot
    21. Alexandra C. Walls
    22. Lauren Carter
    23. David Veesler
    24. Neil P. King
    25. Hun Kim
    26. Ji Hwa Ryu
    27. Su Jeen Lee
    28. Yong Wook Park
    29. Ho Keun Park
    30. Hee Jin Cheong

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)

    1. Taku Kinoshita
    2. Masahiro Shinoda
    3. Yasuhiro Nishizaki
    4. Katsuya Shiraki
    5. Yuji Hirai
    6. Yoshiko Kichikawa
    7. Kenji Tsushima
    8. Masaharu Shinkai
    9. Naoyuki Komura
    10. Kazuo Yoshida
    11. Yasutoshi Kido
    12. Hiroshi Kakeya
    13. Naoto Uemura
    14. Junichi Kadota

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Clinical and Economic Impact of Differential COVID-19 Vaccine Effectiveness in the United States

    1. Michael Maschio
    2. Kelly Fust
    3. Amy Lee
    4. Nicolas Van de Velde
    5. Philip O. Buck
    6. Michele A. Kohli

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Recombinant BA.1/BA.2 SARS-CoV-2 Virus in Arriving Travelers, Hong Kong, February 2022

    1. Haogao Gu
    2. Daisy Y.M. Ng
    3. Gigi Y.Z. Liu
    4. Samuel S.M. Cheng
    5. Pavithra Krishnan
    6. Lydia D.J. Chang
    7. Sammi S.Y. Cheuk
    8. Mani M.Y. Hui
    9. Tommy T.Y. Lam
    10. Malik Peiris
    11. Leo L.M. Poon

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Dupilumab Use Is Associated With Protection From Coronavirus Disease 2019 Mortality: A Retrospective Analysis

    1. Alexandra N Donlan
    2. Indika Mallawaarachchi
    3. Jennifer M Sasson
    4. Robert Preissner
    5. Johanna J Loomba
    6. William A Petri

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 177 of 716 Next